Print

HVTN 203

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of a Combined Regimen Using ALVAC vCP1452 and AIDSVAX B/B

Trial Details:

II Completed
National Institute of Allergy and Infectious Diseases (NIAID), HIV Vaccine Trials Network (HVTN) December 14, 2000
ALVAC vCP1452,AIDSVAX B/B
ALVAC vCP1452 Viral Vector - Pox
AIDSVAX B/B DNA
USA 330
http://www.actis.org; http://www.clinicaltrials.gov http://www.actis.org; http://www.clinicaltrials.gov